A proposed clinical trial involving puberty blockers for young people is expected to include participants as young as 11, according to reporting. The trial has attracted public and legal opposition, with campaigners urging courts to stop it entirely, describing it as an unethical experiment. The reporting also says the trial’s rollout was previously paused earlier this year after officials cited safety concerns. Those officials indicated they wanted to limit the study to older participants, specifically raising the lower age threshold to 14, before any broader implementation. The dispute centers on both the trial’s age range and the conduct of the study, with opponents arguing against proceeding in its current form and supporters maintaining that the research is necessary to evaluate treatment approaches. Details reported across outlets focus on the planned inclusion of children starting at age 11 and the earlier decision to halt or reconsider the trial based on safety-related review. The matter remains under contention as campaigners seek a court intervention to prevent the study from proceeding.